当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 利润表

华东医药

(000963)

  

流通市值:537.88亿  总市值:538.93亿
流通股本:17.51亿   总股本:17.54亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入30,394,530,509.5120,385,344,288.8110,114,531,331.7737,714,587,458.01
营业收入30,394,530,509.5120,385,344,288.8110,114,531,331.7737,714,587,458.01
二、营业总成本27,539,505,233.918,443,622,876.249,111,221,456.7734,568,570,175.18
营业成本20,711,433,505.9213,917,418,061.116,790,724,204.7725,682,497,011.55
税金及附加155,063,860.73106,685,622.9153,150,033.98208,324,645.61
销售费用4,662,350,509.653,083,786,005.031,642,616,610.166,334,738,928.05
管理费用1,105,836,120.39721,477,862.62330,086,070.321,248,781,970.63
研发费用840,788,063.58558,407,142.27265,493,695.71,015,971,052.33
财务费用64,033,173.6355,848,182.329,150,841.8478,256,567.01
其中:利息费用84,321,926.5455,401,149.6734,466,716.93127,654,612.93
其中:利息收入61,683,137.5733,022,555.8712,491,377.82103,350,838.03
加:公允价值变动收益-6,616,639.87-5,100,698.38-28,469,286.61
加:投资收益-168,842,873.72-136,885,042.56-61,752,708.66-141,560,034.56
资产处置收益3,587,637.813,519,820.08-2,199,859.718,257,595.43
资产减值损失(新)-3,175,583.57-3,175,583.57--3,821,625.15
信用减值损失(新)-42,022,538-36,432,398.31--68,689,699.09
其他收益70,617,560.3434,813,373.714,582,456.392,781,468.16
营业利润平衡项目0000
四、营业利润2,708,572,838.61,798,460,883.53953,939,762.933,061,454,274.23
加:营业外收入3,536,981.132,972,826.611,389,195.747,608,417.78
减:营业外支出24,000,14916,298,554.86,049,187.637,938,443.03
利润总额平衡项目0000
五、利润总额2,688,109,670.731,785,135,155.34949,279,771.073,031,124,248.98
减:所得税费用494,560,848.37345,279,440.91189,354,280.74498,498,547.62
六、净利润2,193,548,822.361,439,855,714.43759,925,490.332,532,625,701.36
持续经营净利润2,193,548,822.361,439,855,714.43759,925,490.332,532,625,701.36
归属于母公司股东的净利润2,189,046,844.621,433,824,629.56755,284,976.472,499,214,359.57
少数股东损益4,501,977.746,031,084.874,640,513.8633,411,341.79
(一)基本每股收益1.250.820.431.43
(二)稀释每股收益1.250.820.431.43
八、其他综合收益-3,888,970.61-8,889,448.01-31,351,409.53-40,784,410.62
归属于母公司股东的其他综合收益-3,888,970.61-8,889,448.01-31,351,409.53-40,784,410.62
九、综合收益总额2,189,659,851.751,430,966,266.42728,574,080.82,491,841,290.74
归属于母公司股东的综合收益总额2,185,157,874.011,424,935,181.55723,933,566.942,458,429,948.95
归属于少数股东的综合收益总额4,501,977.746,031,084.874,640,513.8633,411,341.79
公告日期2023-10-252023-08-162023-04-212023-04-14
审计意见(境内)标准无保留意见
TOP↑